
注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
康希诺生物股份公司是一家处于临床阶段的中国疫苗公司。该公司的产品包括埃博拉病毒疫苗Ad5-EBOV、脑膜炎球菌疫苗MCV2和MCV4、肺炎球菌疫苗PBPV和重组新型冠状病毒疫苗等。其产品主要应用于脑膜炎、百白破和肺炎领域。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Shiu Kwan Wai | 58 | 2018 | Independent Non-Executive Director |
George R. Siber | 77 | - | Member of Scientific Advisory Board |
Zhi Xiao | 44 | 2019 | Non-Executive Director |
Tao Zhu | 48 | 2009 | Co-Founder, Executive Director, Deputy GM & Chief Scientific Officer |
Dongxu Qiu | 61 | 2009 | Co-Founder, Executive VP, Executive Director & Deputy GM |
Xuefeng Yu | 58 | 2009 | Co-Founder, Chairman, CEO & GM |
Liang Lin | 48 | 2013 | Non-Executive Director |
Zhu Xin | 53 | 2018 | Independent Non-Executive Director |
Jianzhong Liu | 58 | 2019 | Independent Non-Executive Director |
Liming Li | - | - | Member of Scientific Advisory Board |
Wing Yu Leung | 52 | 2015 | Non-Executive Director |
Luis Barreto | 69 | 2018 | Member of Scientific Advisory Board |
Jiangfeng Li | 45 | 2019 | Chairman of Supervisory Board |
Shuifa Gui | 57 | 2019 | Independent Non-Executive Director |
Shou-Bai Chao | 59 | 2018 | Executive Director, COO & Deputy GM |
Jingren Zhang | - | - | Member of Scientific Advisory Board |
David Briles | - | - | Member of Scientific Advisory Board |
Shan Lu | - | 2022 | Member of the Scientific Advisory Board |
Jing Wang | 41 | 2017 | Chief Commercial Officer, Deputy GM & Executive Director |
Zhongqi Shao | 61 | 2021 | Supervisor |
Yuan Zhou | 35 | 2023 | Employee Representative Supervisor |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核